The FDA employs a comprehensive approach to toxicological risk assessment. This includes reviewing data from laboratory studies, animal testing, and human trials. The agency evaluates the dose-response relationship of substances, which helps in understanding the effects of different exposure levels. The FDA also utilizes toxicokinetic and toxicodynamic data to predict how substances behave in the body and their potential health impacts.
